Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a cfDNA 5mC/5hmC-based Epigenetic Biomarker Panel to Predict Chemotherapy Efficacy in Metastatic Colorectal Cancer

NCT07224815 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT07224815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07224815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a cfDNA 5mC/5hmC-based Epigenetic Biomarker Panel to Predict Chemotherapy Efficacy in Metastatic Colorectal Cancer
Lead sponsor
City of Hope Medical Center
Phase
Observational
Overall status
Recruiting
Start date
June 21, 2024
Completion date
June 18, 2028
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crc (colorectal cancer)